We have sequenced the virulent Asibi strain of yellow fever virus and compared this sequence to that of the 17D vaccine strain, which was derived from it. These two strains of viruses differ by more than 240 passages. We found that the two RNAs, 10,862 nucleotides long, differ at 68 nucleotide positions; these changes result in 32 amino acid differences. Overall, this corresponds to 0.63% nucleotide sequence divergence, and the changes are scattered throughout the genome. The overall divergence at the level of amino acid substitution is 0.94%, but these changes are not randomly distributed among the virus proteins. The capsid protein is unchanged, while proteins NS1, NS3, and NS5 contain 0.5% amino acid substitutions, and proteins ns4a and ns4b average 0.8% substitutions. In contrast, proteins ns2a and ns2b have 3.0 and 2.3% amino acid divergence, respectively. The envelope protein also has a relatively high rate of amino acid change of 2.4% (a total of 12 amino acid substitutions). The large number of changes in ns2a and ns2b, which are largely conservative in nature, may result from lowered selective pressure against alteration in this region; among flaviviruses, these polypeptides are much less highly conserved than NS1, NS3, and NS5. However, many of the amino acid substitutions in the E protein are not conservative. It seems likely that at least some of the difference in virulence between the two strains of yellow fever virus results from changes in the envelope protein that affect virus binding to host receptors. Such differences in receptor binding could result in the reduced neurotropism and vicerotropism exhibited by the vaccine strain.
Yellow fever virus belongs to the Flavivirus genus of the family Flaviviridae, a group of some 70 closely related viruses many of which cause serious human illness (1) . Yellow fever is arthropod-borne, transmitted by mosquitos of the genera Aedes and Haemagogus. Its natural vertebrate host range is limited to primates in which it is viscerotropic and neurotropic. In man, the virus causes a serious, often fatal, illness marked by liver and kidney involvement and hemorrhage. For several hundred years the virus caused epidemics in the Americas, Europe, and Africa that led to widespread human suffering. With the control of the urban vector of yellow fever Aedes aegypti beginning in the early 1900s, epidemic urban yellow fever disappeared. However, the virus remains present in an enzootic cycle in the forests of South America and Africa and causes periodic outbreaks in neighboring human populations.
Reed (2) first proved that yellow fever is transmitted by mosquitos and, shortly thereafter, that the disease agent was filterable. Because there was no recognized, susceptible laboratory host, many years elapsed before the virus responsible was isolated by the Rockefeller Foundation's West Africa yellow fever commission. In 1927, these workers succeeded in isolating a virus from the blood of a young Ghanian named Asibi by monkey/monkey passage (3) . This Asibi strain of yellow fever causes an invariably fatal disease when inoculated into rhesus monkeys.
Theiler (4) developed a live, attenuated vaccine strain, which he referred to as 17D, from the Asibi strain. Starting with the Asibi strain that had been passaged 53 times in monkeys, with intermittent passages in A. aegypti, the virus was propagated serially in cultures of embryonic mouse tissue (18 passages) , minced whole chicken embryo (50 passages), and finally minced chicken embryos without nervous tissue (152 passages). Between the 89th and 114th in vitro passage (from the start of the experiment, that is including the passages in embryonic mouse tissue and whole chicken embryos) a marked change in virulence of the virus occurred. The reason for the change in virulence is unknown and attempts to repeat these experiments by virus passage have failed to develop additional avirulent strains. The 17D strain has been widely used as a human vaccine, being safe and highly effective. It causes a mild, generalized infection in humans (or other primates) with involvement of lymphoid tissue and minimal quantities of virus circulating in the blood, and both the viscerotropism and neurotropism of the parental Asibi virus are markedly reduced.
We have sequenced the genome of a plaque-purified virus derived from the 17D-204 vaccine strain of yellow fever (5) . The 17D-204 strain, supplied by the American Type Culture Collection, had been passed an additional 14 times in chicken embryo tissue culture, for a total of 234 in vitro passages. To obtain RNA for cloning and sequencing, the virus was passed twice in chicken embryo fibroblasts in our laboratory, plaque-purified in Vero cells, and passed twice in BHK cells; virus for RNA preparation was then grown in SW-13 cells (5). Thus, the 17D strain sequenced by us had been passed 240 times in vitro.
We now report the sequence of virtually the entire genome of the Asibi strain of yellow fever and compare the sequences of the 17D and Asibi strains at both the nucleotide level and the amino acid level. In addition to defining the changes that have occurred during 240 serial passages, this work represents a necessary prelude for studying the biological significance of these changes as related to the different virulence of the two strains. 
MATERIALS AND METHODS
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. [4] [5] days after infection (depending upon the first evidence of virus induced cytopathology) and concentrated by polyethylene glycol precipitation. Virus was purified by density-gradient centrifugation on potassium tartrate/glycerol gradients followed by rate-zonal centrifugation on linear sucrose gradients, and the RNA was extracted from NaDodSO4-disrupted virions using a phenol/cresol/8-hydroxyquinoline/chloroform mixture (7) .
Cloning of Asibi cDNA. A cDNA library from Asibi genomic RNA was constructed as described (5, 8) . Ampicillin-resistant colonies from this library were screened by colony hybridization using nick-translated restriction fragments derived from the library of 17D yellow fever clones as probes, as described (9) . Colonies with larger inserts (obtained using cDNA size class of 2 kilobases or larger) were screened with a 5' probe of 2280 base pairs that extends from the 5' end of 17D yellow fever to the first EcoRI site and with a 3' probe of 2580 base pairs, which extends from nucleotide 8280 in 17D to the 3' end, or with probes derived from other regions of the 17D genome. To obtain clones containing the extreme 3' end of the RNA =4000 clones from the smaller insert class (derived from Asibi double-stranded cDNA of 0.8-2 kilobases long) were screened with a fragment derived from the extreme 3' end of 17D. This fragment, 150 nucleotides long, extends from the Xba I site at nucleotide 10,708 to the 3' end of 17D yellow fever. We found three positive clones with this probe, two of which were identical. One of these clones had an unusual structure and probably arose by self-priming; it was used to obtain the Asibi sequence through to the 3'-terminal nucleotide.
Sequence Analysis of Asibi cDNA. Plasmid DNA from selected Asibi clones was sequenced using the chemical method (10, 11) as described (12) .
RESULTS
Sequence of Asibi Yellow Fever. The sequencing strategy used to obtain the nucleotide sequence of Asibi yellow fever is diagramed in Fig. 1 . The sequence obtained was completely overlapped and was determined for at least two independent clones throughout virtually the entire genome. This allowed the detection of heterogeneity in the cloned cDNA population (either due to heterogeneity in the RNA genomes cloned or due to errors introduced during reverse transcription and subsequent cloning). Since the RNA templates that were used for cloning were not derived from plaque-purified virus, such clonal differences might be expected, and we found six nucleotides that differed between two clones. The sequence obtained totaled 10,848 nucleotides and represents the entire Asibi genomic RNA sequence with the exception of the 5'-terminal 14 nucleotides.
Comparison of Nucleotide Sequences of 17D and Asibi Yellow Fever. All of the nucleotide differences found between Asibi and 17D yellow fever are shown in Fig. 2 . Clonal Clones 3 and 5 start with the 15th and 17th nucleotide, respectively, from the 5' end of the yellow fever genome. The 3'-terminal 111 nucleotides were present in only one clone, 3'-1, whose structure is complex and which probably arose by self-priming. In all other regions at least two independent clones were sequenced. differences found among the Asibi clones are also presented. A total of 68 nucleotide differences were found between the two strains that had been fixed and an additional 6 nucleotides that differed in two different clones of Asibi yellow fever. In each clonal difference detected, one of the nucleotides found at a given position was the same as that found in 17D yellow fever. The sequence of 17D yellow fever that has been reported is a consensus sequence derived from sequencing more than one clone throughout the entire region (5) . With a total of 68 changes (0.63% of the genome) there was an average of about 0.27 change fixed per passage. Assuming an effective multiplication of 210 at each passage, this would represent 2 x 10-6 change fixed per nucleotide per generation. Changes presumably occur more frequently than this but do not survive selection pressure during continued passage.
The nucleotide changes are summarized as to transitions and transversions in Fig. 3 . Transitions are five times more common than transversions, as expected if most of the changes occur by mispairing during RNA replication.
Nucleotide changes are scattered throughout the genome but occurred more frequently in the envelope protein region (1.0% nucleotide sequence difference), in the ns2a region (1.6% difference), in the ns2b region (1.0% difference), and in the 3'-noncoding region (1.2% difference) (Fig. 4) . Changes in the untranslated region may be more frequent because of a relative lack of selective pressure against changes that occur in these regions, although it is ofinterest that no changes were found in the 5'-untranslated region. Within Changes in Amino Acid Sequence. Amino acid differences between 17D and Asibi yellow fever are given in Fig. 2 and summarized in Fig. 4 Proteins E, ns2a, and ns2b exhibit a disproportionately high rate of change, 2.4% for E, 3% for ns2a, and 2.3% for ns2b. Only 13 changes, or less than half of the total changes found between Asibi and 17D, are found in other regions, an amino acid sequence divergence of only 0.5%.
The function of the various nonstructural proteins in virus replication is unknown. However, NS3 and NS5 probably form components of the viral replicase responsible for replicating RNA. If these proteins do possess enzymatic functions, then amino acid changes might be expected to be deleterious and selected against during continued passage. It is of note that most of the changes found in NS5 occur near the ends of the molecule, with only one change occurring within the central 75% of the protein. It is unknown whether NS1 has enzymatic activity, but it has been postulated that since it is a glycoprotein, it may be involved in virus assembly. The fact that amino acid substitutions in NS1 are rare, as was the case for NS3 and NS5, suggests that whatever role it plays in virus replication, it requires a precise amino acid sequence for that function. NS1, NS3, and NS5 demonstrate a high degree of conservation among different flaviviruses (13) .
The small polypeptides ns2a, ns2b, ns4a, and ns4b are hydrophobic in nature and are not highly conserved among flaviviruses (13) . Their hydrophobicity profiles are remarkably conserved, however, suggesting that as long as the hydrophobicity profile is unchanged, a large number of amino acid substitutions can be accommodated without affecting the normal function of these proteins. The high frequency of change observed in the ns2 region may simply be a reflection ofthis; many of the changes that arise may not affect function and are, therefore, not selected against. The amino acid changes found in the ns2 region (Fig. 2) 17) . In this report we detail the differences in nucleotide and amino acid sequence between this vaccine strain and the parental Asibi isolate from which it was derived. The change or changes responsible for the altered virulence or attenuation of 17D cannot be determined at the current time. Indeed, the situation is complicated by the fact that the 17D vaccine contains a mixture of variants that differ in a number of biological properties (17, 18) . It is unclear which of these variants was sequenced to obtain the 17D sequence, since the vaccine strain was plaque-purified before amplification and sequencing. It is unknown if this mixture of variants is important for the vaccine properties of the 17D strain; however, reversion to virulence has never been documented. It is known that a change occurred in the virulence of yellow fever between the 89th and 114th passage; that this change, once it occurred, was stable; and that comparable changes were not obtained when the passage history of the 17D strain was repeated. The Asibi strain sequenced was not plaque purified and a number of clonal differences were found.
Attenuation of a virus by propagation in tissue culture presumably results from selection for variants better adapted for replication in tissue culture and, conversely, less-well adapted for replication in their natural hosts, although accumulation and fixation of nonselected mutations may also be important. In particular, variants might be selected that bind more readily to receptors on cultured chicken cells, leading to more rapid attachment and penetration. Such an alteration in receptor binding could, as a consequence, lead to lessefficient binding to receptors found in hepatocytes or neurons in primates, and thus to an alteration in tissue tropism and reduction in virulence. The large number of changes found in the envelope protein is consistent with such an hypothesis. Changes elsewhere in the genome may also be important, however, particularly if they affect the efficiency of virus replication. Because of the stability of the vaccine strain, it is likely that more than one change is important for its avirulence. If it becomes possible to rescue infectious virus from a cloned cDNA copy of yellow fever, as has been done for several RNA viruses (19) (20) (21) , it will be possible to test the effect of the individual changes found on the virulence of the virus. Such an approach has been used with the Sabin and 
